Krystal Biotech buy Chardan Capital
Start price
12.12.24
/
50%
€165.85
Target price
12.12.25
€201.99
Performance (%)
25.47%
End price
13.12.25
€208.10
Summary
This prediction ended on 13.12.25 with a price of €208.10. The BUY prediction by Chardan_Capital finished with a performance of 25.47%. Chardan_Capital has a follow-up prediction for Krystal Biotech where he still thinks Krystal Biotech is a Buy. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Krystal Biotech | 10.418% | 10.418% | 100.326% |
| iShares Core DAX® | 4.642% | 7.489% | 6.987% |
| iShares Nasdaq 100 | 4.471% | 16.803% | 40.281% |
| iShares Nikkei 225® | 7.670% | 16.856% | 47.874% |
| iShares S&P 500 | 2.472% | 9.903% | 28.430% |
Comments by Chardan_Capital for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $212.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat
In the thread Trading Krystal Biotech
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Current prediction by Chardan_Capital for Krystal Biotech
Stopped prediction by Chardan_Capital for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€172.25
20.02.25
20.02.25
€208.60
20.02.26
20.02.26
27.14%
21.02.26
21.02.26
Krystal Biotech
Start price
Target price
Perf. (%)
€151.90
18.12.24
18.12.24
€202.14
18.12.25
18.12.25
30.09%
19.12.25
19.12.25